- Home
- FXNC vs GNLX Comparison
FXNC vs GNLX Comparison
Compare FXNC & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FXNC | GNLX |
|---|---|---|
| Founded | 1907 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 234.3M | 202.4M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | FXNC | GNLX |
|---|---|---|
| Price | $28.15 | $2.57 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $19.75 |
| AVG Volume (30 Days) | 37.5K | ★ 377.3K |
| Earning Date | 01-29-2026 | 11-05-2025 |
| Dividend Yield | ★ 2.45% | N/A |
| EPS Growth | ★ 96.00 | N/A |
| EPS | ★ 1.96 | N/A |
| Revenue | ★ $86,993,000.00 | N/A |
| Revenue This Year | $7.52 | N/A |
| Revenue Next Year | $4.47 | N/A |
| P/E Ratio | $14.15 | ★ N/A |
| Revenue Growth | ★ 49.95 | N/A |
| 52 Week Low | $18.26 | $1.99 |
| 52 Week High | $27.80 | $8.54 |
Technical Indicators
Market Signals| Indicator | FXNC | GNLX |
|---|---|---|
| Relative Strength Index (RSI) | 76.13 | 30.60 |
| Support Level | $25.35 | $2.61 |
| Resistance Level | $26.00 | $2.97 |
| Average True Range (ATR) | 0.59 | 0.18 |
| MACD | 0.21 | 0.05 |
| Stochastic Oscillator | 82.82 | 18.04 |
Price Performance
Historical ComparisonAbout FXNC First National Corporation
First National Corp is a bank holding company of First Bank, which is a commercial bank. Its core offering includes loans, deposits, wealth management, and other products and services. The Company operates through two reportable operating segments: Community Banking and wealth management. The Community Banking segment involves making loans and generating deposits from individuals, businesses, and charitable organizations. Wealth Management Services offers corporate trustee services, trust and estate administration, IRA administration and custody services. Key revenue is generated from Community Banking.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.